Does Perrigo Company plc have an economic moat?

Based on its FY2025 SEC filings, the Moat Index scores Perrigo Company plc (PRGO) 31.3 out of 100 — below the Shallow-moat bar, so no moat. The four filters behind that score (each 0–100): pricing power 60, returns on capital 0, balance-sheet safety 28, capital discipline 40.

Is PRGO stock trading below its intrinsic value?

Against a deliberately conservative owner-earnings model (9% discount rate, 0% assumed growth, capped at 4%), estimated intrinsic value is $7.36 per share versus a recent price of $10.72 — 46% above value. This is an educational estimate computed from primary SEC filings, not investment advice.

How has PRGO's Moat Score changed over time?

The record logs 3 readings since Jul 17, 2026; the latest reads 31.3 out of 100 (no moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

The Moat Index

Perrigo Company plc

PRGO · Healthcare · $1.5B mkt cap · FY2025 filings · No moat ·

Doesn't clear the bar

No moat

The four filters

Pricing power60

Median gross margin 36.3% over 10y, very stable.

Returns on capital0

Median ROIC 1.7%, above the 9% hurdle in 0% of years.

Balance-sheet safety28

Net debt/EBITDA n/ax, interest coverage 0x.

Capital discipline40

Owner earnings trend unclear, share count growing (dilution).

Margin of safety

Above valueOn sale

46% above value

Owner earnings (normalized): $91.2M
Est. intrinsic value / share: $7.36
Recent price: $10.72
Discount to value: 46% above value

Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

15 years of fundamentals

The business, in plain English

Perrigo Company plc booked $4.3B of revenue in FY2025 in the Healthcare sector and kept 35.1% of it as gross profit — a solid-margin business by that measure. After every other cost, −33.5% of each revenue dollar reached the bottom line.

Across the filed record, revenue grew from $3.2B (FY2012) to $4.3B (FY2025) — about 2.3% a year compounded over 13 years.

It earned −14.7% on invested capital in FY2025, with a median of 2.2% across 14 filed years. The Returns on Capital filter above scores it 0/100.

The balance sheet carried $3.6B of total debt in FY2025. Balance-Sheet Safety scores it 28/100.

Put together: Pricing Power is the strongest of the four filters (60/100) and Returns on Capital the weakest (0/100), which is how PRGO lands at 31/100 — a None moat.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.

RevenueSales, as filed$4.3B FY2025

Gross marginRevenue kept after cost of goods35.1% FY2025

Return on invested capitalOperating profit on the capital employed−14.7% FY2025

Owner earningsCash an owner could take out−$1.2B FY2025

Gaps in a line mean that item isn’t in PRGO’s filings for that year — the series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.

Moat Score history

Moat Score over timeLast scored reading of each day, on the 0–100 scale31.3 / 100

Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — PRGO has read No moat for every logged capture since Jul 17, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Healthcare context

#342 of 440 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

#340AMRX AMNEAL PHARMACEUTICALS, INC.31.5 out of 100, No moatNo moat
#341EMMA EMMAUS LIFE SCIENCES, INC.31.4 out of 100, No moatNo moat
#343URGN UroGen Pharma Ltd.31.3 out of 100, No moatNo moat
#344LCTC LIFELOC TECHNOLOGIES, INC.30.9 out of 100, No moatNo moat

Compare PRGO with its nearest peers →All Healthcare companies on the Index →

Common questions about PRGO

Does Perrigo Company plc have an economic moat?: Based on its FY2025 SEC filings, the Moat Index scores Perrigo Company plc (PRGO) 31.3 out of 100 — below the Shallow-moat bar, so no moat. The four filters behind that score (each 0–100): pricing power 60, returns on capital 0, balance-sheet safety 28, capital discipline 40.
Is PRGO stock trading below its intrinsic value?: Against a deliberately conservative owner-earnings model (9% discount rate, 0% assumed growth, capped at 4%), estimated intrinsic value is $7.36 per share versus a recent price of $10.72 — 46% above value. This is an educational estimate computed from primary SEC filings, not investment advice.
How has PRGO's Moat Score changed over time?: The record logs 3 readings since Jul 17, 2026; the latest reads 31.3 out of 100 (no moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

Embed this score on your site

One iframe, no script. The badge shows PRGO’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/PRGO"
  width="340" height="150" style="border:0"
  title="PRGO Moat Score — The Moat Index"
  loading="lazy"></iframe>

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell PRGO. See the disclaimer.